Arvinas (ARVN) FCF Margin Growth (5y) (2022 - 2026)
Arvinas (ARVN) FCF Margin Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,946.26 Bn | 1,946.20 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.25 Bn | 468.46 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.17 Bn | 115.92 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.54 Bn | 60.79 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.20 Bn | 63.20 Bn | - |
| 8 | Argenx Se | 56.91 Bn | 51.72 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.23 Bn | 38.23 Bn | - |
| 10 | Arvinas | 531.52 Mn | -83.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,535.00 |
| Dec 31, 2025 | 24,234.00 |
| Sep 30, 2025 | 12,166.00 |
| Jun 30, 2025 | -2,716.00 |
| Mar 31, 2025 | 24,618.00 |
| Dec 31, 2024 | 10,056.00 |
| Sep 30, 2024 | -11,727.00 |
| Jun 30, 2024 | 39,487.00 |
| Mar 31, 2024 | -5,890.00 |
| Dec 31, 2023 | 48,967.00 |
| Sep 30, 2023 | 14,270.00 |
| Jun 30, 2023 | 19,427.00 |
| Mar 31, 2023 | -75,373.00 |
| Dec 31, 2022 | -124,311.00 |